Recruiting
Addtional Effect of Hyperbaric Oxygen to Programmed Physical Activity on Musckoloskeletal Pain in Breast Cancer Elderly
patienst who survived from breast cancer are prescribed long administraion of aromatase inhbitors.. these inhibitors usually induce musckloskeletal pains. Programmed phsyical activity are reommended to improve these pains but effects of HYperbaric oxygen on these pain was not investigated
ClinicalTrials.gov IDNCT07662629
PhaseNA
Enrollment40
SponsorCairo University
Age65 Years – 75 Years
SexFEMALE
Conditions studied
Breast Cancer
About this study
patienst who survived from breast cancer are prescribed long administraion of aromatase inhbitors.. these inhibitors usually induce musckloskeletal pains. Programmed phsyical activity are reommended to improve these pains but effects of HYperbaric oxygen on these pain was not investigated
Interventions
- Other: hyperbaric therapy and exercise — Twenty elder survivors from breast cancer with musckolskeletal pains resultes from aromatase inhibitor intake received phsyical activity program (aerobci training on traedmill and strengtheining protcol thrice weekly fro 2 month) and additinally received one-hour hyperbaric therapy session , five times weekly for 2 month.
- Other: exercise — Twenty elder survivors from breast cancer with musckolskeletal pains resultes from aromatase inhibitor intake received phsyical activity program (aerobci training on traedmill and strengtheining protcol thrice weekly for 2 month).
Primary outcomes
- visual analogue scale (it will be measured after 2 months)
Eligibility information
Inclusion Criteria:
* braest cancer survivors
* patients receiving aramatase inhibitor drugs
* patients with musckolskeletal pains
Exclusion Criteria:
* cardiac patients
* respiratory patients
* renal patients
Study locations
- Cairo University, Dokki, Giza Governorate 11432 Egypt
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-07.